Climb Bio (CLYM) Total Liabilities (2020 - 2026)

Climb Bio's Total Liabilities history runs 7 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• Quarterly Total Liabilities fell 41.71% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 41.71% YoY) and the FY2025 annual result came in at $7.3 million, up 37.0% from the prior year.
• Total Liabilities was $4.3 million for Q1 2026 at Climb Bio, down from $7.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $7.9 million in Q2 2022 and bottomed at $2.9 million in Q4 2023.
• A 5-year average of $5.2 million and a median of $5.3 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities plunged 54.28% — and 2025, when it jumped 149.32%.
• Climb Bio's Total Liabilities stood at $6.3 million in 2022, then plunged by 54.28% to $2.9 million in 2023, then surged by 84.88% to $5.3 million in 2024, then surged by 37.0% to $7.3 million in 2025, then tumbled by 41.02% to $4.3 million in 2026.
• Business Quant data shows CLYM's Total Liabilities at $4.3 million in Q1 2026, $7.3 million in Q4 2025, and $5.3 million in Q3 2025.